Y Intercept Hong Kong Ltd Reduces Stake in The Cooper Companies, Inc. $COO

Y Intercept Hong Kong Ltd lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 96.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,968 shares of the medical device company’s stock after selling 80,078 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Cooper Companies were worth $203,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Mn Services Vermogensbeheer B.V. lifted its holdings in shares of Cooper Companies by 1.6% in the third quarter. Mn Services Vermogensbeheer B.V. now owns 74,708 shares of the medical device company’s stock worth $5,122,000 after buying an additional 1,200 shares in the last quarter. UniSuper Management Pty Ltd increased its holdings in Cooper Companies by 22.2% during the 3rd quarter. UniSuper Management Pty Ltd now owns 37,021 shares of the medical device company’s stock worth $2,538,000 after acquiring an additional 6,717 shares during the period. Tranquilli Financial Advisor LLC purchased a new stake in Cooper Companies in the 3rd quarter worth approximately $261,000. Parkside Financial Bank & Trust boosted its holdings in Cooper Companies by 181.1% in the 3rd quarter. Parkside Financial Bank & Trust now owns 936 shares of the medical device company’s stock valued at $64,000 after purchasing an additional 603 shares during the period. Finally, Rakuten Investment Management Inc. purchased a new position in shares of Cooper Companies during the 3rd quarter valued at $11,341,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of Cooper Companies stock opened at $80.10 on Friday. The firm has a market capitalization of $15.70 billion, a PE ratio of 42.61, a price-to-earnings-growth ratio of 2.31 and a beta of 1.03. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $96.78. The business’s 50-day moving average price is $81.29 and its 200-day moving average price is $74.44.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The business had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the firm earned $1.04 earnings per share. Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Insider Activity at Cooper Companies

In other Cooper Companies news, Director Lawrence Erik Kurzius bought 2,000 shares of Cooper Companies stock in a transaction that occurred on Wednesday, December 17th. The shares were bought at an average price of $82.50 per share, with a total value of $165,000.00. Following the acquisition, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This trade represents a 34.62% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Holly R. Sheffield purchased 1,230 shares of the stock in a transaction on Tuesday, December 16th. The stock was acquired at an average cost of $80.75 per share, with a total value of $99,322.50. Following the completion of the purchase, the insider directly owned 39,052 shares of the company’s stock, valued at $3,153,449. The trade was a 3.25% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 16,014 shares of company stock worth $1,304,416 in the last 90 days. Corporate insiders own 1.98% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on COO. Morgan Stanley increased their price objective on Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Monday, December 8th. Stifel Nicolaus set a $95.00 price target on Cooper Companies and gave the company a “buy” rating in a report on Friday, December 5th. Wells Fargo & Company lifted their price target on Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, December 5th. Piper Sandler restated an “overweight” rating and issued a $94.00 price objective (up from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Finally, Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $90.77.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.